glp 1 on medicaid McKee's proposed FY2027 budget drops GLP-1 drugs for weight loss from • Rhode Island Current Patients Face New Barriers for

Figure 12: Photograph Professor Vincent Marks (1930-2023), credit: Seaton)

Shima Hadidchi MDs practice with obesity, high blood pressure, type 2 diabetes, or high cholesterol

A case series published in late 2025 in SAGE Open Medical Case Reports by Tinsley (Texas Tech University) and Nadolsky (Vineyard Health) provides the first detailed published body composition trajectories from a virtual obesity medicine practice that emphasizes structured resistance training and protein targets alongside incretin therapy

doi:10.1371/journal.pone.0039656 89

Most patients report decreased hunger and earlier satiety within the first one to two weeks of starting GLP-1 therapy